Cargando…
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
Cutaneous melanoma (CM) is a life-threatening form of skin cancer. Prognostic biomarkers can reliably stratify patients at initial melanoma diagnosis according to risk, and may inform clinical decisions. Here, we performed a retrospective, cohort-based study analyzing genome-wide DNA methylation of...
Autores principales: | Guo, Wenna, Zhu, Liucun, Zhu, Rui, Chen, Qihan, Wang, Qiang, Chen, Jian-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553943/ https://www.ncbi.nlm.nih.gov/pubmed/31169496 http://dx.doi.org/10.7554/eLife.44310 |
Ejemplares similares
-
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
por: Guo, Wenna, et al.
Publicado: (2018) -
Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
por: Guo, Wenna, et al.
Publicado: (2022) -
Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma
por: Chen, Yuxiao, et al.
Publicado: (2020) -
Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020) -
A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)